The Regulatory Navigator is an Integrated Regulatory Information Management Tool for RegDocs Connect
Montreal, QC - Montrium, regulatory compliance specialists, and enterprise content management software providers, today, announced the commercial release of the Regulatory Navigator, an interactive intelligence dashboard integrated into RegDocs Connect, their Regulatory EDMS. Equipped with powerful business intelligence and intuitive regulatory document management, pharmaceutical organizations now have the tools to significantly improve the quality of their content while speeding up the submission timeline.
As the FDA deadline for eCTD submissions approaches and the complexity of drug development continues to increase, life sciences companies need sophisticated and easy to use tools that help them produce submission-ready, quality content in a timely manner. By combining document creation, dossier management, product registrations, and health authority interactions in one place, life sciences companies can increase the speed, efficiency, agility and compliance of their regulatory teams.
"Traditionally, Life Sciences companies have struggled with disconnected regulatory landscape, where information is managed in several systems, and in multiple regions," said Paul Fenton, President & CEO at Montrium. "The Regulatory Navigator, paired with RegDocs Connect marries essential RIM functionality with powerful document authoring and management, allowing regulatory teams to create, plan and track the entire regulatory timeline, in one place."
Much like Montrium's other Navigator tools, the Regulatory Navigator provides visual indicators that provide clarity and transparency over the completeness of your submissions, ensuring that everything you send for publishing is submission-ready. Regulatory teams can now quickly identify all available, expected, in-process or missing submission documents by products, regions, countries, applications or sequences and begin creating regulatory activities directly in the navigator.
The Regulatory Navigator is now available globally as part of Montrium's RegDocs Connect product. To learn more about Navigator Tools or to schedule a demo of the Regulatory Navigator, please register for our live demonstration where we will be giving attendees an exclusive walkthrough of the Regulatory Navigator.
Additional Information
About Montrium
Montrium is a global leader in cloud-based document & quality management solutions (QMS) and GxP consulting services for the Life Sciences. Operating in the Life Sciences for over ten years, Montrium has been successfully helping organizations implement and maintain technology to improve their business processes and increase compliance. Montrium currently serves over 7500 satisfied users in over 20 countries. For more information on the products and services Montrium provides, please visit their website: www.montrium.com
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
Vabysmo Shows Significant Vision Improvement for Diabetic Macular Edema in Underrepresented Patients
October 22nd 2024Phase IV ELEVATUM trial results show that one year of treatment with Vabysmo significantly improved vision in underrepresented racial and ethnic groups with diabetic macular edema, supporting the drug's efficacy and safety across diverse populations.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Clesrovimab Shows Significant Reduction in RSV Infections, Hospitalizations in Infants
October 18th 2024Merck's investigational monoclonal antibody, clesrovimab, shows significant efficacy in reducing respiratory syncytial virus-related infections and hospitalizations in infants, with a favorable safety profile.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
Vabysmo Shows Significant Vision Improvement for Diabetic Macular Edema in Underrepresented Patients
October 22nd 2024Phase IV ELEVATUM trial results show that one year of treatment with Vabysmo significantly improved vision in underrepresented racial and ethnic groups with diabetic macular edema, supporting the drug's efficacy and safety across diverse populations.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Clesrovimab Shows Significant Reduction in RSV Infections, Hospitalizations in Infants
October 18th 2024Merck's investigational monoclonal antibody, clesrovimab, shows significant efficacy in reducing respiratory syncytial virus-related infections and hospitalizations in infants, with a favorable safety profile.
2 Commerce Drive
Cranbury, NJ 08512